What We Do     Team     Therapeutic Areas     Partnering     News     Contact

2018

 

2016

 

2015

 

2014

 

2012

 

2011

 

2010

 

2009

 

2008

 

2007

 

Brainsway joins Mexico through an exclusive distribution deal with moksha8

 

Brainsway LTD (TASE: BRIN), leader in non-invasive brain stimulation, is pleased to announce a new alliance with moksha8, a leading company in the marketing of medicines for the CNS in Latin America, for the exclusive distribution of Transcranial Magnetic Stimulation Deep in Mexico. Moksha8 intends to register and start the marketing of several Deep EMT devices in 2016 and has already committed to launch 10 devices in the next 12 months.

 

“Brainsway is excited to announce this new alliance. I am sure that with Brainsway technology and the presence of moksha8 in the Mexican market, we will have a great success opening a new horizon for Deep EMT technology. We hope to be able to make the treatment affordable for the majority of patients suffering from major depression in Mexico, who are desperately seeking new solutions. The agreement reflects Brainsway’s strategy to expand its facilities, “said Dr. Guy Ezekiel, President and CEO of Brainsway.

 

Mexico is a highly promising market for Brainsway Deep EMT, since no other EMT device has been approved in this country. Under this agreement, moksha8 will promote registration, medical education and in-sales activities related to Deep EMT in Mexico.

 

“We are excited to bring the Deep EMT to Mexico. It is a perfect complement to our portfolio of CNS drugs, since the need for an effective and non-invasive solution for patients with depression is enormous, “said Joel Barlan, CEO of moksha8. “Brainsway technology is an innovative solution eagerly awaited.”

 

About Brainsway

 

Braisnway is a leading company dedicated to the development of treatments for brain disorders. Brainsway Deep TMS (Transcranial Magnetic Stimulation) effectively treats non-invasive depression, avoiding side effects, and is effective for patients resistant to treatment of depression. Brainsway’s technology was approved by the FDA for the treatment of patients with depression who did not respond to several pharmacological treatments in the depressive episode. Brainsway Deep EMT was enthusiastically received by the international academic community, with 60 clinical trials in various institutions globally. For more information, please visit www.brainsway.com

 

COPYRIGHT © 2006-2018 MOKSHA8 PHARMACEUTICALS, INC. ALL RIGHTS RESERVED. THIS INFORMATION—INCLUDING PRODUCT INFORMATION—IS INTENDED ONLY FOR RESIDENTS OF THE UNITED STATES. THE PRODUCTS DISCUSSED HEREIN MAY HAVE DIFFERENT LABELING IN DIFFERENT COUNTRIES.